Company Badge
USPTO Data Jan 1 1976 - Nov 3 2026
4 Patents
#2 in Vaerlose
#551 in Denmark
Egalet A/s
Forward Citations = 48
6 inventors:
Egalet A/s
Calculating rank
% Expired Patents = 25.0
CIPO Patents = 1
EPO Patents = 2
Forward Citations = 48
Loading Chart...
Loading Chart...
6 inventors (with patents filed for the assignee):
Lillian Slot (3 out of 12 patents)
Gina Engslev Fischer (3 out of 14 patents)
Daniel K Bar-Shalom (3 out of 28 patents)
4. Pernille Høyrup Hemmingsen (2 out of 2 patents)
5. Anne-Marie Lademann (1 out of 4 patents)
6. Martin Rex Olsen (1 out of 1 patent)
7. Christine Andersen (11 patents)
8. Pernille Hoyrup Hemmingsen (2 patents)
9. Gina Fischer (0 patent)
10. Gina Fischer (0 patent)
11. Gina Fischer (0 patent)
12. Daniel Bar-Shalom (0 patent)
4 patents:
Company Overview
Egalet A/S is a specialty pharmaceutical company focused on developing, manufacturing, and commercializing innovative treatments for pain and other central nervous system disorders. The company's novel technology platform allows for the controlled release of medications, providing patients with extended-release options for managing their conditions.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Egalet A/s. Retrieved from https://idiyas.com/company/egalet-a-s
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]